Non-animal testing methods formally recognized for preclinical drug safety by regulator

The United States Food and Drug Administration (US FDA) has issued a direct final rule clarifying that validated non-animal testing methods can be used for preclinical drug safety evaluations. The rule updates regulatory terminology from animal tests to nonclinical tests, supporting the adoption of cell based assays, organ on chips, and computer models in human drug development applications.

Join our 1500+ subscribers to get our daily Health Laws and Policy Updates.